Laman Utama207940 • KRX
add
Samsung Biologics Co Ltd
Tutup sebelumnya
₩1,116,000.00
Julat hari
₩1,110,000.00 - ₩1,145,000.00
Julat tahun
₩721,000.00 - ₩1,209,000.00
Permodalan pasaran
79.71T KRW
Bilangan Purata
76.58K
Nisbah P/E
73.58
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.26T | 17.04% |
Perbelanjaan pengendalian | 334.17B | 87.16% |
Pendapatan bersih | 321.49B | 10.60% |
Margin untung bersih | 25.59 | -5.50% |
Pendapatan bagi setiap syer | 4.52K | 10.60% |
EBITDA | 476.48B | -3.14% |
Kadar cukai berkesan | 14.04% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.33T | -35.26% |
Jumlah aset | 17.34T | 8.04% |
Jumlah liabiliti | 6.43T | 3.47% |
Jumlah ekuiti | 10.90T | — |
Syer tertunggak | 71.17J | — |
Harga kepada buku | 7.28 | — |
Pulangan pada aset | 4.88% | — |
Pulangan pada modal | 6.80% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 321.49B | 10.60% |
Tunai daripada operasi | 389.56B | -53.23% |
Tunai daripada pelaburan | -1.07T | -138.92% |
Tunai daripada pembiayaan | 514.35B | 280.15% |
Perubahan bersih dalam tunai | -149.00B | -267.89% |
Aliran tunai bebas | -30.00B | -107.16% |
Perihal
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
CEO
Diasaskan
2011
Tapak web
Pekerja
4,744
